Sign Up to like & get recommendations! 0
Published in 2020 at "Clinical Cardiology"
DOI: 10.1002/clc.23334
Abstract: It was found that delayed activation wave often appeared in terminal QRS wave in non‐ST‐elevated myocardial infarction (NSTEMI) with culprit vessel in left circumflex artery (LCX), yet little is known about the similarities among non‐“N”‐wave… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "American Journal of Clinical Pathology"
DOI: 10.1093/ajcp/aqz116.004
Abstract: Non-ST-elevated myocardial infarction diagnoses rely more heavily on lab values. In this study, we examined the effectiveness of an algorithm calculating delta rise in troponins to identify critical values. Using this algorithm in combination with… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Journal of Hypertension"
DOI: 10.1097/01.hjh.0000548811.02956.4b
Abstract: Objectives: To examine the consequences of elevated myocardial wall stress (MWS) in children with and without chronic kidney disease (CKD). Methods: 100 children (10.6 ± 3.0 years) including 66 children with CKD were studied for two visits… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Coronary Artery Disease"
DOI: 10.1097/mca.0000000000000798
Abstract: The causal relationship of lipoprotein(a) with cardiovascular disease has been established. However, clinical impacts of lipoprotein(a) levels on adverse vascular events in patients with established coronary artery disease who are undergoing statin treatment have not… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Medicine"
DOI: 10.1097/md.0000000000010359
Abstract: Background: Bone marrow mononuclear cell (BMMNC) therapy has been used as an adjunctive treatment in patients with ST-elevated myocardial infarction (STEMI). However, the therapeutic efficacy of this approach remains controversial. The present meta-analysis is aimed… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Blood"
DOI: 10.1182/blood-2018-99-116105
Abstract: Introduction:Fibrinolysis plays an important role in the treatment of ST-elevated myocardial infarction (STEMI) when percutaneous coronary intervention is not readily available. Early and successful myocardial reperfusion with thrombolytic therapy effectively reduces the infarct size and… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "PLoS ONE"
DOI: 10.1371/journal.pone.0188202
Abstract: Background Recently, it was shown that interleukin-17A (IL-17A) is involved in the pathophysiology of reperfusion injury and associated with infarct size (IS) in experimental models of myocardial infarction. Our aim was to evaluate whether the… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Yonsei Medical Journal"
DOI: 10.3349/ymj.2018.59.5.611
Abstract: Purpose Results on the clinical utility of cell therapy for ST-elevated myocardial infarction (STEMI) are controversial. This study sought to analyze the efficacy of treatment with intracoronary bone marrow mononuclear cells (BMMC) on left ventricular… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Frontiers in Cardiovascular Medicine"
DOI: 10.3389/fcvm.2022.874436
Abstract: The ability of blood transcriptome analysis to identify dysregulated pathways and outcome-related genes following myocardial infarction remains unknown. Two gene expression datasets (GSE60993 and GSE61144) were downloaded from Gene Expression Omnibus (GEO) Datasets to identify… read more here.